<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
<front>
<journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id><journal-id journal-id-type="pmc">plospath</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Pathogens</journal-title></journal-title-group><issn pub-type="ppub">1553-7366</issn><issn pub-type="epub">1553-7374</issn><publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="publisher-id">10-PLPA-RA-3161R2</article-id><article-id pub-id-type="doi">10.1371/journal.ppat.1001040</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Infectious Diseases/Bacterial Infections</subject><subject>Microbiology/Cellular Microbiology and Pathogenesis</subject><subject>Microbiology/Microbial Physiology and Metabolism</subject></subj-group></article-categories><title-group><article-title>The <italic>Mycobacterium tuberculosis</italic> Proteasome Active Site Threonine Is Essential for Persistence Yet Dispensable for Replication and Resistance to Nitric Oxide</article-title><alt-title alt-title-type="running-head">Proteasome Function in <italic>M. tuberculosis</italic></alt-title></title-group><contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gandotra</surname><given-names>Sheetal</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lebron</surname><given-names>Maria B.</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ehrt</surname><given-names>Sabine</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group><aff id="aff1">          <addr-line>Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States of America</addr-line>       </aff><contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Rubin</surname><given-names>Eric J.</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group><aff id="edit1">Harvard School of Public Health, United States of America</aff><author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">sae2004@med.cornell.edu</email></corresp>
<fn fn-type="con"><p>Conceived and designed the experiments: SG MBL SE. Performed the experiments: SG MBL. Analyzed the data: SG MBL SE. Wrote the paper: SG SE.</p></fn>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn></author-notes><pub-date pub-type="collection"><month>8</month><year>2010</year></pub-date><pub-date pub-type="epub"><day>12</day><month>8</month><year>2010</year></pub-date><volume>6</volume><issue>8</issue><elocation-id>e1001040</elocation-id><history>
<date date-type="received"><day>20</day><month>4</month><year>2010</year></date>
<date date-type="accepted"><day>13</day><month>7</month><year>2010</year></date>
</history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2010</copyright-year><copyright-holder>Gandotra et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract>
<p>Previous work revealed that conditional depletion of the core proteasome subunits PrcB and PrcA impaired growth of <italic>Mycobacterium tuberculosis in vitro</italic> and in mouse lungs, caused hypersusceptibility to nitric oxide (NO) and impaired persistence of the bacilli during chronic mouse infections. Here, we show that genetic deletion of <italic>prcBA</italic> led to similar phenotypes. Surprisingly, however, an active site mutant proteasome complemented the <italic>in vitro</italic> and <italic>in vivo</italic> growth defects of the <italic>prcBA</italic> knockout (<italic>ΔprcBA</italic>) as well as its NO hypersensitivity. In contrast, long-term survival of <italic>M. tuberculosis</italic> in stationary phase and during starvation <italic>in vitro</italic> and in the chronic phase of mouse infection required a proteolytically active proteasome. Inhibition of inducible nitric oxide synthase did not rescue survival of <italic>ΔprcBA</italic>, revealing a function beyond NO defense, by which the proteasome contributes to <italic>M. tuberculosis</italic> fitness during chronic mouse infections. These findings suggest that proteasomal proteolysis facilitates mycobacterial persistence, that <italic>M. tuberculosis</italic> faces starvation during chronic mouse infections and that the proteasome serves a proteolysis-independent function.</p>
</abstract><abstract abstract-type="summary"><title>Author Summary</title>
<p>The eukaryotic proteasome is ubiquitous and essential for many basic cellular processes. In contrast to most bacteria, which do not express a proteasome, <italic>Mycobacterium tuberculosis</italic> encodes a proteasome predicted to be essential or required for optimal growth of the pathogen. Genetic silencing of the proteasome core genes further suggested that the <italic>M. tuberculosis</italic> proteasome plays an important role in defense against nitric oxide and in persistence of the pathogen during chronic mouse infections. In this manuscript we generated a genetic deletion mutant of the proteasome core genes proving that the 20S proteasome is not essential for growth of <italic>M. tuberculosis</italic>. We complemented the proteasome knockout with a proteolytically active and a mutated, proteolysis defective proteasome. This revealed that proteasomal proteolysis is dispensable for <italic>in vitro</italic> and <italic>in vivo</italic> growth and nitric oxide resistance of <italic>M. tuberculosis</italic> and suggests that the proteasome core serves a proteolysis-independent function. In contrast, long-term survival of the pathogen <italic>in vitro</italic> and in the chronic phase of mouse infection required a proteolytically active proteasome. We further provide evidence that nitric oxide is not responsible for killing of the proteasome knockout during chronic mouse infections. Thus, proteasomal proteolysis facilitates mycobacterial persistence independently of defense against nitric oxide. We propose that the failure to survive starvation contributes to the impaired persistence of <italic>M. tuberculosis</italic> lacking a proteolytically active proteasome during chronic infections.</p>
</abstract><funding-group><funding-statement>This work was supported in part by the I.T. Hirschl Trust (SE); MBL was supported by NIH grant T32 AI007621. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="10"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Most cells continuously synthesize and degrade proteins in a regulated manner. Protein degradation is highly selective and this is achieved in part by localization of protease active sites within a barrel-shaped complex. This self-compartmentalization was first discovered for the proteasome <xref ref-type="bibr" rid="ppat.1001040-Arrigo1">[1]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Baumeister1">[2]</xref>. In all genera, the proteasome consists of a 20S cylindrical core particle, which contains two heptameric outer rings composed of α subunits, and two heptameric inner rings composed of the proteolytically active β subunits. The 20S proteasome belongs to the class of N-terminal nucleophile (Ntn) hydrolases, with a hydroxyl group of the amino-(N) terminal threonine functioning as catalytic nucleophile that reacts with peptide bonds of substrates or the electrophilic functional groups of proteasome inhibitors <xref ref-type="bibr" rid="ppat.1001040-Kisselev1">[3]</xref>.</p>
<p>Bacterial proteasomes are only found in Actinomycetes <xref ref-type="bibr" rid="ppat.1001040-Lupas1">[4]</xref>, while other chambered proteases such as ClpAP, ClpXP, Lon, HslUV and FtsH are common in most bacteria <xref ref-type="bibr" rid="ppat.1001040-DeMot1">[5]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Gottesman1">[6]</xref>. <italic>Mycobacterium tuberculosis</italic> encodes a proteasome and two CLP proteases, but lacks homologs of Lon and HslUV <xref ref-type="bibr" rid="ppat.1001040-Cole1">[7]</xref>. The proteasome accessory factors, <italic>Mycobacterium</italic> proteasomal ATPase (Mpa) and proteasome accessory factor A (PafA), are important for defense against reactive nitrogen intermediates (RNI) and for virulence of <italic>M. tuberculosis</italic> in the mouse <xref ref-type="bibr" rid="ppat.1001040-Darwin1">[8]</xref>. Mpa assembles into a hexameric ATPase similar to the archeal proteasome associating nucleotidase (PAN) and the eukaryotic regulatory 19S cap <xref ref-type="bibr" rid="ppat.1001040-Darwin2">[9]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Neuwald1">[10]</xref>. The <italic>M. tuberculosis</italic> 20S proteasome harbors electron dense plugs at the barrel ends created by the N-termini of its α subunits <xref ref-type="bibr" rid="ppat.1001040-Hu1">[11]</xref>. Removal of the N-terminal eight amino acids resulted in enhanced peptidolytic activity, suggesting that the <italic>M. tuberculosis</italic> proteasome has a gated structure and implying a role for accessory factors including Mpa in “gate opening” <xref ref-type="bibr" rid="ppat.1001040-Darwin2">[9]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Lin1">[12]</xref>, <xref ref-type="bibr" rid="ppat.1001040-CerdaMaira1">[13]</xref>. A direct interaction of purified Mpa with the 20S open gate mutant proteasome was demonstrated by electron microscopy <xref ref-type="bibr" rid="ppat.1001040-Wang1">[14]</xref>.</p>
<p>In eukaryotic cells a covalently attached polymeric chain of ubiquitin targets proteins for degradation by the proteasome <xref ref-type="bibr" rid="ppat.1001040-Kerscher1">[15]</xref>. In <italic>M. tuberculosis</italic>, Pup, a prokaryotic ubiquitin-like protein, is ligated by PafA to proteasomal substrate proteins and serves as degradation signal <xref ref-type="bibr" rid="ppat.1001040-Pearce1">[16]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Burns1">[17]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Striebel1">[18]</xref>. Pup must be deamidated by Dop (deamidase of Pup) to activate it for conjugation to a substrate <xref ref-type="bibr" rid="ppat.1001040-Pearce1">[16]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Burns1">[17]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Striebel1">[18]</xref>. <italic>In vitro</italic> reconstitution assays with purified Dop, PafA, Pup, ATP and substrate proteins FabD (malonyl acyltransferase) or PanB (ketopantoate hydroxymethyltranferase) revealed that Dop and PafA are necessary and sufficient for <italic>in vitro</italic> pupylation of proteasome target proteins. Accordingly pupylation was severely impaired and PanB and FabD accumulated in an <italic>M. smegmatis dop</italic> deletion mutant <xref ref-type="bibr" rid="ppat.1001040-Imkamp1">[19]</xref>. Recently, the Mpa-proteasome complex has been reconstituted <italic>in vitro</italic> and shown to unfold and degrade Pup-tagged substrates via interaction of Mpa with Pup <xref ref-type="bibr" rid="ppat.1001040-Striebel2">[20]</xref>. Interestingly Pup is degraded together with the substrate, in contrast to ubiquitin, which is recycled.</p>
<p>Numerous pupylated proteins of diverse cellular functions have been identified in <italic>M. smegmatis</italic> and <italic>M. tuberculosis</italic> <xref ref-type="bibr" rid="ppat.1001040-Festa1">[21]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Watrous1">[22]</xref>. The overlap between nitrosylated and pupylated proteins suggests that the proteasome is important for turnover of nitrosylated proteins <xref ref-type="bibr" rid="ppat.1001040-Watrous1">[22]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Rhee1">[23]</xref>. This hypothesis is substantiated by hypersusceptibility to reactive nitrogen intermediates (RNI) of <italic>M. tuberculosis</italic> lacking proteasome associated factors or depleted for the proteasome core subunits PrcBA <xref ref-type="bibr" rid="ppat.1001040-Darwin1">[8]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Gandotra1">[24]</xref>. However, it is unclear if accumulation of nitrosylated proteins or any other proteasome substrate(s) caused the growth and persistence defects of proteasome deficient <italic>M. tuberculosis</italic> in mouse lungs. To gain more insight into proteasome core function, we constructed a <italic>prcBA</italic> deletion mutant (<italic>ΔprcBA</italic>) and complemented it with either an active wild type core proteasome or a proteolytically defective, active site mutant proteasome. Our data suggest that proteasomal proteolysis is dispensable for <italic>in vitro</italic> and <italic>in vivo</italic> replication of <italic>M. tuberculosis</italic> and for resistance to RNI. Inhibition of inducible nitric oxide synthase (iNOS) did not affect killing of <italic>ΔprcBA</italic>, indicating that defense against NO is likely not a major activity by which the proteasome facilitates mycobacterial persistence. However, <italic>M. tuberculosis</italic> expressing the proteolysis defective proteasome was severely impaired in stationary phase survival, died in response to carbon starvation and failed to persist during chronic mouse infections. Thus, the <italic>M. tuberculosis</italic> proteasome may promote survival <italic>in vivo</italic> by opposing starvation.</p>
</sec><sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>The 20S core proteasome is not essential but is required for optimal growth and resistance to nitric oxide</title>
<p>The genes encoding the <italic>M. tuberculosis</italic> proteasome core subunits PrcB and PrcA were predicted to be essential or required for optimal growth <italic>in vitro</italic> <xref ref-type="bibr" rid="ppat.1001040-Sassetti1">[25]</xref>. Conditional depletion of the proteasome core subunits via transcriptional silencing of <italic>prcBA</italic> resulted in impaired growth on agar plates and in liquid culture <xref ref-type="bibr" rid="ppat.1001040-Gandotra1">[24]</xref>. Here, we genetically deleted <italic>prcBA</italic> (<xref ref-type="supplementary-material" rid="ppat.1001040.s001">Figure S1</xref>) resulting in loss of proteasome activity (<xref ref-type="fig" rid="ppat-1001040-g001">Figure 1A</xref>). Expression of <italic>prcBA</italic> from a constitutive promoter on an episomal plasmid restored PrcB expression and proteasome activity in the complemented mutant (<italic>ΔprcBA</italic>+PrcBA) (<xref ref-type="fig" rid="ppat-1001040-g001">Figure 1A</xref>, <xref ref-type="supplementary-material" rid="ppat.1001040.s001">S1C</xref>). The <italic>prcBA</italic> knockout (<italic>ΔprcBA</italic>) was viable, yet impaired for growth on agar plates and had a small but reproducible growth defect in liquid culture, confirming previous observations (<xref ref-type="fig" rid="ppat-1001040-g001">Figure 1B, C</xref>). The growth defects were restored in the complemented mutant. These data demonstrate that while the core proteasome is required for optimal growth of <italic>M. tuberculosis in vitro</italic>, it is not essential. The growth defect of <italic>ΔprcBA</italic> was more evident on agar plates than in liquid medium, similar to what we previously observed after <italic>prcBA</italic> silencing <xref ref-type="bibr" rid="ppat.1001040-Gandotra1">[24]</xref>.</p>
<fig id="ppat-1001040-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1001040.g001</object-id><label>Figure 1</label><caption>
<title>The proteasome is required for optimal growth <italic>in vitro</italic> and for resistance to RNI.</title>
<p>(<bold>A</bold>) Proteasome activities in H37Rv, <italic>ΔprcBA</italic> and the complemented mutant (<italic>ΔprcBA</italic> + PrcBA). The cleavage velocity (RFU/min) of the fluorogenic peptide substrate Suc-LLVY-AMC reports proteasome activity. Proteasome activity was not detectable in <italic>ΔprcBA</italic>. Data are means ± s.d. of three independent experiments. (<bold>B</bold>) Growth of H37Rv, <italic>ΔprcBA</italic> and <italic>ΔprcBA</italic> + PrcBA on agar plates. Serial dilution of the three stains were spotted onto 7H11 agar plates and incubated for 3 weeks at 37°C. (<bold>C</bold>) Growth of H37Rv, <italic>ΔprcBA</italic> and <italic>ΔprcBA</italic> + PrcBA in liquid culture. Strains were inoculated in 7H9 media and growth was followed by measuring OD<sub>580</sub>. (<bold>D</bold>) Susceptibility to reactive nitrogen intermediates. Colony forming units (CFU) of H37Rv, <italic>ΔprcBA</italic> and the complemented strain after three days exposure to 0 mM and 3 mM sodium nitrite at pH 5.5. Data are means ± s.d. of triplicate cultures and representative of three independent experiments.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1001040.g001" xlink:type="simple"/></fig>
<p><italic>M. tuberculosis</italic> mutants that lack the mycobacterial proteasome ATPase Mpa or the Pup ligase PafA or are depleted for PrcBA are hypersusceptible to RNI <xref ref-type="bibr" rid="ppat.1001040-Darwin1">[8]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Gandotra1">[24]</xref>. Similarly, viability of <italic>ΔprcBA</italic> was almost ten-fold reduced compared to wt <italic>M. tuberculosis</italic> after exposure to acidified sodium nitrite (<xref ref-type="fig" rid="ppat-1001040-g001">Figure 1D</xref>). This increased killing was complemented when PrcBA were expressed from a plasmid. Thus, the 20 S proteasome core is required for resistance against RNI <italic>in vitro</italic>.</p>
</sec><sec id="s2b">
<title>The core proteasome is required for virulence in immune competent and immune compromised mice</title>
<p>The mouse model of tuberculosis is characterized by an acute phase, in which the bacteria replicate actively for approximately three weeks and a chronic phase, during which the bacteria persist at stable numbers. Silencing of <italic>prcBA</italic> reduced replication of <italic>M. tuberculosis</italic> during the acute phase and persistence during the chronic phase of infection in mouse lungs <xref ref-type="bibr" rid="ppat.1001040-Gandotra1">[24]</xref>. Genetic deletion of <italic>prcBA</italic> similarly affected <italic>in vivo</italic> growth and persistence of <italic>M. tuberculosis</italic> (<xref ref-type="fig" rid="ppat-1001040-g002">Figure 2A, B</xref>). At three weeks post infection CFU in lungs were 1.5 log<sub>10</sub> lower in <italic>ΔprcBA</italic> infected mice than in mice infected with wt <italic>M. tuberculosis</italic> and at 16 weeks post infection this difference increased to 2 log<sub>10</sub> (<italic>P</italic> = 0.001 and <italic>P</italic> = 0.009). The virulence defects were fully restored in the complemented mutant. Nitric oxide generated by inducible nitric oxide synthase (iNOS) is required to control mycobacterial replication in mice <xref ref-type="bibr" rid="ppat.1001040-MacMicking1">[26]</xref> and lack of proteasome activity resulted in increased susceptibility of <italic>M. tuberculosis</italic> to RNI (<xref ref-type="fig" rid="ppat-1001040-g001">Figure 1D</xref>). To determine if NO produced by iNOS was responsible for the decline in viability of <italic>ΔprcBA</italic> during the chronic phase of the infection, infected mice were treated with an iNOS-specific inhibitor L-<italic>N<sup>6</sup></italic>-iminoethyl-lysine (L-NIL) <xref ref-type="bibr" rid="ppat.1001040-Moore1">[27]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Stenger1">[28]</xref> starting at day 25 post infection (<xref ref-type="fig" rid="ppat-1001040-g002">Figure 2C</xref>). In mice infected with wt <italic>M. tuberculosis</italic>, L-NIL treatment resulted in a failure to control bacterial replication, so that bacillary loads were increased by two orders of magnitude in lungs at 25 days post treatment (day 50 post infection) compared to the control group treated with the inactive enantiomer (D-NIL) (<xref ref-type="fig" rid="ppat-1001040-g002">Figure 2C</xref>). The remaining L-NIL-treated mice infected with wt <italic>M. tuberculosis</italic> succumbed between day 50 and day 75 post-infection. In contrast, only a 2-fold increase in bacillary burden of <italic>ΔprcBA</italic> was observed in lungs upon L-NIL treatment compared to D-NIL treatment at 25 days post treatment. L-NIL treated mice infected with <italic>ΔprcBA</italic> survived until the end of the experiment (day 200), and bacterial numbers in the lungs of both L-NIL and D-NIL treated mice declined by 20-fold (<xref ref-type="fig" rid="ppat-1001040-g002">Figure 2C</xref>). There was only a slight increase in the number of nodular lesions at day 200 in mice infected with <italic>ΔprcBA</italic> and treated with L- Nil compared to D-Nil treated mice (not shown). Altogether, these data suggest that iNOS is not required to control <italic>ΔprcBA</italic> during chronic infection in mice.</p>
<fig id="ppat-1001040-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1001040.g002</object-id><label>Figure 2</label><caption>
<title>The proteasome is required for optimal growth and persistence in mice.</title>
<p>(<bold>A</bold>) Bacterial titers in lungs of C57BL/6 mice infected by aerosol with H37Rv, <italic>ΔprcBA</italic> and the complemented mutant. Data are means ± s.d. from four mice per time point per group and are representative of three independent experiments. (<bold>B</bold>) Gross pathology of lungs infected with H37Rv, <italic>ΔprcBA</italic> and complemented mutant at day 116 post-infection. (<bold>C</bold>) Bacterial titers in lungs of C57BL/6 mice infected by aerosol with H37Rv and <italic>ΔprcBA</italic> and treated with the iNOS inhibitor L-Nil and its inactive enantiomer D-Nil starting at day 25 post-infection (indicated by arrow). Data are means ± s.d. from four mice per time point per group and represent two independent experiments.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1001040.g002" xlink:type="simple"/></fig></sec><sec id="s2c">
<title>Mutation of the PrcB active site residue threonine dramatically impairs proteolytic activity</title>
<p>The 20S proteasome is a multimeric protein complex and we hypothesized that lack of expression of the proteasome core subunits PrcB and PrcA could have different physiological consequences than lack of PrcB-mediated proteolytic activity. To test this, we expressed a proteasome active site mutant in <italic>ΔprcBA</italic>. In this mutant, the N-terminal threonine residue of the mature PrcB subunit was mutated to alanine (T1A). This mutation abolished proteolytic activity of the proteasome from <italic>Thermoplasma acidophilum</italic> <xref ref-type="bibr" rid="ppat.1001040-Kisselev1">[3]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Seemuller1">[29]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Seemuller2">[30]</xref>. To allow assembly of this mutant proteasome subunit into a 20S complex, we also deleted the pro-peptide of the PrcB subunit, which in an active proteasome is autocatalytically removed by the active site Thr, thereby exposing the amino group of Thr for nucleophilic attack on the target peptide bond <xref ref-type="bibr" rid="ppat.1001040-Lin1">[12]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Seemuller1">[29]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Zuhl1">[31]</xref>. Similar mutagenesis of the <italic>T. acidophilum</italic> proteasome allowed assembly of a mature 20S proteasome core <xref ref-type="bibr" rid="ppat.1001040-Seemuller1">[29]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Zuhl1">[31]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Zwickl1">[32]</xref>. The mutated <italic>prcB</italic> gene (<italic>pcrB</italic>T1A) was cloned including a C-terminal histidine tag in an operon with <italic>prcA</italic> (<italic>prcAB</italic>T1A) and expressed in <italic>ΔprcBA</italic>. Immunoprecipitation of the PrcB subunit from lysates of this <italic>M. tuberculosis</italic> strain co-purified PrcA as determined by liquid chromatography-tandem mass spectrometry (<xref ref-type="supplementary-material" rid="ppat.1001040.s002">Figure S2</xref>) indicating that a complex containing both subunits formed <italic>in vivo</italic> despite the PrcBT1A mutation. As expected, the mutant proteasome failed to complement proteolytic activity of <italic>ΔprcBA</italic>, measured by cleavage of the peptide substrate Suc-LLVY-AMC (<xref ref-type="fig" rid="ppat-1001040-g003">Figure 3A</xref>), although the expression level of the PrcB subunit containing the T1A mutation was similar to that of wt PrcB (<xref ref-type="fig" rid="ppat-1001040-g003">Figure 3B</xref>). To determine whether the T1A mutation affected proteolytic activity within the bacteria, GFP was fused to the proteasome substrate PanB (ketopantoate hydroxymethyltransferase). PanB has been shown to accumulate in <italic>M. tuberculosis</italic> lacking Mpa and in wt <italic>M. tuberculosis</italic> treated with the proteasome inhibitor epoxomicin <xref ref-type="bibr" rid="ppat.1001040-Pearce2">[33]</xref>. We confirmed by 2-D SDS page analysis that PanB also accumulated in <italic>ΔprcBA</italic> (not shown). Similarly, the PanB-GFP fusion protein accumulated in <italic>ΔprcBA</italic> compared to wt <italic>M. tuberculosis</italic> as shown by GFP activity (<xref ref-type="fig" rid="ppat-1001040-g003">Figure 3C</xref>) and GFP protein levels (<xref ref-type="fig" rid="ppat-1001040-g003">Figure 3D</xref>). This was complemented when the intact core proteasome (PrcBA) was expressed in <italic>ΔprcBA</italic>. In contrast, the active site mutant proteasome (PrcAB-T1A) did not revert the accumulation of PanB-GFP (<xref ref-type="fig" rid="ppat-1001040-g003">Figure 3C, D</xref>). Thus, the active site mutation T1A not only abolished proteasome activity against a peptide substrate <italic>in vitro</italic>, but also disrupted proteolytic activity of the proteasome within the bacteria.</p>
<fig id="ppat-1001040-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1001040.g003</object-id><label>Figure 3</label><caption>
<title>Characterization of the active site mutant proteasome.</title>
<p>(<bold>A</bold>) Proteasome activities of H37Rv, <italic>ΔprcBA</italic> and <italic>ΔprcBA</italic> complemented with the active site mutant proteasome (PrcAB-T1A) and the intact proteasome (PrcBA) measured using the fluorogenic substrate Suc-LLVY-AMC. Proteasome activity was not detectable in <italic>ΔprcBA</italic> and <italic>ΔprcBA</italic> complemented with the active site mutant proteasome (PrcAB-T1A). (<bold>B</bold>) PrcB levels analyzed by immunoblotting in lysates from H37Rv, <italic>ΔprcBA</italic> and the complemented strains. DlaT was used as loading control. (<bold>C</bold>) GFP activities in strains expressing GFP or the PanB-GFP fusion protein. (<bold>D</bold>) GFP and PanB-GFP levels analyzed by immunoblotting in lysates from H37Rv, <italic>ΔprcBA</italic> and the complemented strains. DlaT was used as loading control.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1001040.g003" xlink:type="simple"/></fig></sec><sec id="s2d">
<title>The active site mutant proteasome enables optimal growth <italic>in vitro</italic> and <italic>in vivo</italic>, confers RNI resistance but is not sufficient for persistence in mice</title>
<p>Surprisingly, expression of PrcAB-T1A in <italic>ΔprcBA</italic> complemented its growth defect both on solid and in liquid media similar to expression of wt PrcBA (<xref ref-type="fig" rid="ppat-1001040-g004">Figure 4A, B</xref>). The RNI hypersusceptibility of <italic>ΔprcBA</italic> was also complemented to a large degree by the active site mutant proteasome (<xref ref-type="fig" rid="ppat-1001040-g004">Figure 4C</xref>). We next asked if the catalytic activity of the proteasome is required for <italic>M. tuberculosis</italic> to grow and persist in mice. The mutant proteasome complemented the <italic>in vivo</italic> growth defect of <italic>ΔprcBA</italic> similar to the wt proteasome (<xref ref-type="fig" rid="ppat-1001040-g005">Figure 5A</xref>), suggesting that a proteolysis-independent activity of the 20S core is required for optimal growth of <italic>M. tuberculosis</italic> in mouse lungs. However, the persistence defect of <italic>ΔprcBA</italic> during the chronic phase of infection was not complemented by the T1A mutant proteasome and bacterial numbers in the lungs declined by 3 log<sub>10</sub> between day 28 and day 200. Similarly, lung pathology, which was easily detectable on day 56 post-infection, decreased from day 56 to day 200 in mice infected with the T1A mutant proteasome complemented <italic>ΔprcBA</italic> (<xref ref-type="fig" rid="ppat-1001040-g005">Figure 5B</xref>). Of note, <italic>ΔprcBA</italic> complemented with the mutant proteasome lost viability faster than <italic>ΔprcBA</italic> in mouse lungs (<xref ref-type="fig" rid="ppat-1001040-g005">Figure 5A</xref>). The higher bacterial burden reached by the strain expressing the mutant proteasome at three weeks post infection likely resulted in a more efficient activation of the immune system resulting in faster killing of the bacilli. This hypothesis is supported by the increased kinetics of killing of <italic>ΔprcBA</italic> in the face of a higher bacterial burden when mice were infected with a mixture of equal numbers of wt <italic>M. tuberculosis</italic> and <italic>ΔprcBA</italic> (<xref ref-type="fig" rid="ppat-1001040-g005">Figure 5C</xref>).</p>
<fig id="ppat-1001040-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1001040.g004</object-id><label>Figure 4</label><caption>
<title>The active site mutant proteasome complements the growth defects and RNI hypersusceptibility of the proteasome KO.</title>
<p>(<bold>A</bold>) Growth of H37Rv, <italic>ΔprcBA</italic> and the complemented strains in liquid culture. Strains were inoculated in 7H9 media and growth was followed by measuring OD<sub>580</sub>. (<bold>B</bold>). Growth of H37Rv, <italic>ΔprcBA</italic> and the complemented strains on agar plates. Serial dilutions of the indicated stains were spotted onto 7H11 agar plates and incubated for 3 weeks at 37°C. (<bold>C</bold>) Susceptibility to reactive nitrogen intermediates. Colony forming units (CFU) of H37Rv, <italic>ΔprcBA</italic> and the complemented strains after three days exposure to 0 mM, 3 mM or 5 mM sodium nitrite at pH 5.5. Data are means ± s.d. of triplicate cultures and representative of three independent experiments.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1001040.g004" xlink:type="simple"/></fig><fig id="ppat-1001040-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1001040.g005</object-id><label>Figure 5</label><caption>
<title>The active site mutant proteasome complements the <italic>in vivo</italic> growth defect but not the persistence defect of the proteasome KO.</title>
<p>(<bold>A</bold>) Bacterial titers in lungs of C57BL/6 mice infected by aerosol with <italic>ΔprcBA</italic> and <italic>ΔprcBA</italic> complemented with wild type and the active site T1A mutant ptroteasome. Data are means ± s.d. from four mice per time point per group and represent two independent experiments. (<bold>B</bold>) Gross pathology of lungs infected with <italic>ΔprcBA</italic> and <italic>ΔprcBA</italic> complemented with the wild type and the active site mutant proteasome at day 56 and day 120 post-infection. (<bold>C</bold>) Bacterial titers in lungs of C57BL/6 mice infected by aerosol with a mixed culture of H37Rv with a streptomycin resistance conferring plasmid integrated in the chromosomal attB site (H37Rv<sub>strep</sub>) and the hygromycin resistant <italic>ΔprcBA</italic>.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1001040.g005" xlink:type="simple"/></fig>
<p>Altogether, these data suggest that the proteolytic activity of the proteasome is dispensable for growth of <italic>M. tuberculosis in vitro</italic> and in mice and for RNI resistance, yet proteasome mediated proteolysis is required for persistence of <italic>M. tuberculosis</italic> in mouse lungs.</p>
</sec><sec id="s2e">
<title>A proteolytically active proteasome is required for survival in stationary phase and during starvation</title>
<p>Proteasomal proteolysis may be required during bacteriostasis or periods of slow replication to counter the effects of accumulating protein damage as well as to provide amino acids for energy metabolism during starvation. Proteolysis mediated by ClpP and Lon is important for the ability of <italic>E. coli</italic> to sustain starvation <xref ref-type="bibr" rid="ppat.1001040-Damerau1">[34]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Kuroda1">[35]</xref>. We monitored survival during stationary phase and during complete starvation of wt <italic>M. tuberculosis</italic>, <italic>ΔprcBA</italic> and <italic>ΔprcBA</italic> complemented with the wt proteasome and the T1A active site mutant proteasome. In normal growth medium, <italic>M. tuberculosis</italic> grew exponentially for about 10 days, after which bacterial numbers remained almost constant over the next 170 days (<xref ref-type="fig" rid="ppat-1001040-g006">Figure 6A</xref>). <italic>ΔprcBA</italic> was, as expected from earlier growth characterizations, impaired for growth. Upon entering stationary phase, viability of the <italic>ΔprcBA</italic> declined steadily. At 180 days post inoculation there was an approximately 3 log<sub>10</sub> difference in viable counts between wt and <italic>ΔprcBA</italic> (<xref ref-type="fig" rid="ppat-1001040-g006">Figure 6A</xref>). Both the growth and persistence defects were largely complemented by expression of the wt proteasome. The T1A mutant proteasome complemented the initial growth defect but failed to complement the persistence defect. Wt <italic>M. tuberculosis</italic> and <italic>ΔprcBA</italic> transformed with the wt proteasome also survived conditions of complete starvation without a significant decline in viability (<xref ref-type="fig" rid="ppat-1001040-g006">Figure 6B</xref>). In contrast, viability of <italic>ΔprcBA</italic> and <italic>ΔprcBA</italic> transformed with the T1A mutant proteasome declined steadily during starvation (<xref ref-type="fig" rid="ppat-1001040-g006">Figure 6B</xref>). Collectively, these data indicate that the proteasomal proteolysis is important for the ability of <italic>M. tuberculosis</italic> to survive conditions of starvation and stationary phase <italic>in vitro</italic>.</p>
<fig id="ppat-1001040-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1001040.g006</object-id><label>Figure 6</label><caption>
<title>A proteolytically intact core proteasome is required for long-term survival in stationary phase and during starvation.</title>
<p>(<bold>A</bold>) Growth and survival of H37Rv, <italic>ΔprcBA</italic> and the complemented strains in complete 7H9 growth medium. (<bold>B</bold>) Survival of H37Rv, <italic>ΔprcBA</italic> and the complemented strains in phosphate buffered saline. CFU were determined at indicated times by plating on 7H11 agar plates. Data are means ± s.d. of triplicates and representative of three independent experiments.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1001040.g006" xlink:type="simple"/></fig></sec></sec><sec id="s3">
<title>Discussion</title>
<p>The eukaryotic proteasome is ubiquitous and essential for many basic cellular processes including differentiation, proliferation, transcription, signal transduction, metabolic regulation, immune surveillance and others <xref ref-type="bibr" rid="ppat.1001040-Dahlmann1">[36]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Jung1">[37]</xref>. In prokaryotes, proteasome deletion mutants have been generated in <italic>Thermoplasma acipophilum</italic>, <italic>Streptomyces lividans</italic>, <italic>S. coelicolor</italic> and <italic>M. smegmatis</italic>. <italic>T. acidophilum</italic> proteasome mutants were impaired for survival post heat shock but not under normal growth conditions <xref ref-type="bibr" rid="ppat.1001040-Ruepp1">[38]</xref>. Deletion of the proteasome in <italic>S. lividans</italic>, <italic>S. coelicolor</italic> and <italic>M. smegmatis</italic> did not reveal phenotypic defects <xref ref-type="bibr" rid="ppat.1001040-Hong1">[39]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Knipfer1">[40]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Nagy1">[41]</xref>. The current work proves that the 20S proteasome is not essential for growth of <italic>M. tuberculosis</italic>. However, consistent with previous studies <xref ref-type="bibr" rid="ppat.1001040-Gandotra1">[24]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Sassetti1">[25]</xref> lack of the core proteasome resulted in a growth defect on plates and in liquid culture, suggesting that proteasome-mediated proteolysis is important for optimal <italic>in vitro</italic> growth of <italic>M. tuberculosis</italic>.</p>
<p>Surprisingly, however, a proteolytically defective proteasome fully complemented the growth defects and partially restored the RNI hypersusceptibility of <italic>ΔprcBA</italic>. Thus, these phenotpyes of <italic>ΔprcBA</italic> are likely not due to lack of proteasomal proteolysis. We cannot exclude that mutation of the active site threonine to alanine failed to completely abolish proteolysis. However, peptidolytic activity of the proteasome was undetectable in lysates expressing the T1A mutant proteasome and the proteasome substrate PanB tagged with GFP accumulated similarly in <italic>ΔprcBA</italic> and <italic>ΔprcBA</italic> expressing the T1A mutant proteasome. Thus, proteasome-mediated proteolysis was drastically impaired when the active site threonine was mutated to alanine in PrcB. The 20S core requires accessory factors for protein targeting to the proteolytic chamber <xref ref-type="bibr" rid="ppat.1001040-Darwin3">[42]</xref>. In eukaryotes, proteasome accessory factors are not only found as part of the proteasome complex; they also form subcomplexes that regulate transcription and DNA repair and have chaperone function <xref ref-type="bibr" rid="ppat.1001040-Chen1">[43]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Ferdous1">[44]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Nishiyama1">[45]</xref>. The stoichiometry of proteasome accessory factors that are free or in complex with the 20S core might be regulated. In the absence of the 20S core an excess of free accessory factors might affect growth. The T1A active-site mutant proteasome is likely to interact with Mpa and potentially other proteasome accessory factors despite its catalytic defect and thereby prevent phenotypes caused by an imbalance of free and complexed accessory factors.</p>
<p>Depletion of the 20S proteasome in <italic>M. tuberculosis</italic> caused hypersusceptibility to RNI and impaired persistence in the mouse <xref ref-type="bibr" rid="ppat.1001040-Gandotra1">[24]</xref>. Deletion of Mpa and PafA sensitized <italic>M. tuberculosis</italic> to RNI <italic>in vitro</italic> and resulted in impaired growth in the mouse <xref ref-type="bibr" rid="ppat.1001040-Darwin1">[8]</xref>. However, the proteolytically defective active site mutant proteasome complemented the RNI hypersusceptibility of <italic>ΔprcBA</italic> to a large degree, suggesting that proteasomal proteolysis is not essential for conferring RNI resistance. Moreover, inhibition of iNOS, the major producer of nitric oxide in macrophages, had no impact on survival of <italic>ΔprcBA</italic> in mouse lungs. Thus other factors of the adaptive immune response appear responsible for killing <italic>ΔprcBA</italic> during the chronic phase of the infection. Of note, the attenuated growth of the <italic>M. tuberculosis</italic> Mpa mutant in the acute phase of infection was not rescued in iNOS-deficient mice <xref ref-type="bibr" rid="ppat.1001040-Darwin1">[8]</xref>. Phagocyte oxidase activity may have compensated for inhibited iNOS activity; however, proteasome-depleted <italic>M. tuberculosis</italic> and the Mpa mutant were hyperresistant to oxidative stress <italic>in vitro</italic> <xref ref-type="bibr" rid="ppat.1001040-Darwin1">[8]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Gandotra1">[24]</xref>.</p>
<p>We propose that nutrient limitation might be responsible for the killing of <italic>ΔprcBA</italic> in mice. <italic>M. tuberculosis</italic> lacking the 20S core failed to survive prolonged stationary phase and nutrient starvation <italic>in vitro</italic> and was unable to persist <italic>in vivo</italic>. Proteasome-mediated proteolytic turnover seems essential for <italic>in vitro</italic> and <italic>in vivo</italic> persistence of <italic>M. tuberculosis</italic>, because the active site mutant proteasome expressing strain phenocopied the inability of <italic>ΔprcBA</italic> to persist both <italic>in vitro</italic> and <italic>in vivo</italic>. Nutritionally starved and clinically persistent <italic>M. tuberculosis</italic> share phenotypic similarities, including reduced acid-fastness and drug tolerance <xref ref-type="bibr" rid="ppat.1001040-Betts1">[46]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Nyka1">[47]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Wayne1">[48]</xref>. Starvation of <italic>M. tuberculosis</italic> reduced respiration to minimal levels, indicating a low metabolic activity, but the bacilli remained viable and were recoverable when returned to rich medium <xref ref-type="bibr" rid="ppat.1001040-Loebel1">[49]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Loebel2">[50]</xref>. Nutrient starvation-induced transcripts can be detected in human tuberculous granulomas <xref ref-type="bibr" rid="ppat.1001040-Betts1">[46]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Fenhalls1">[51]</xref>. Moreover, the stringent response, required for long-term survival in culture, was also required for persistence of <italic>M. tuberculosis</italic> in mice <xref ref-type="bibr" rid="ppat.1001040-Dahl1">[52]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Primm1">[53]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Stallings1">[54]</xref>. In <italic>E. coli</italic> amino acid starvation is followed by increased ribosomal protein degradation via Lon protease to provide amino acids for the synthesis of new enzymes important for adaptation to starvation <xref ref-type="bibr" rid="ppat.1001040-Kuroda1">[35]</xref>, <xref ref-type="bibr" rid="ppat.1001040-Kuroda2">[55]</xref>. Moreover, starvation and growth arrest are linked to the production of misfolded and aberrant proteins isoforms that need to be degraded to prevent toxicity <xref ref-type="bibr" rid="ppat.1001040-Nystrom1">[56]</xref>. In mammalian cells proteasomal protein degradation is crucial in supplying amino acids for the synthesis of new proteins during amino acid deprivation <xref ref-type="bibr" rid="ppat.1001040-Vabulas1">[57]</xref>. Similarly, <italic>M. tuberculosis</italic> might require the proteasome for amino acid supply and turnover of damaged proteins during long term persistence within its host.</p>
<p>In summary, this work demonstrates the essential role of the 20S proteasome proteolytic activity for <italic>M. tuberculosis</italic> to persist <italic>in vivo</italic> and reveals a mechanism beyond nitric oxide defense by which the proteasome contributes to mycobacterial fitness.</p>
</sec><sec id="s4" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s4a">
<title>Ethics statement</title>
<p>All mouse procedures performed in this study were conducted following the National Institutes of Health guidelines for housing and care of laboratory animals and performed in accordance with institutional regulations after protocol review and approval by the Institutional Animal Care and Use Committee of Weill Cornell Medical College.</p>
</sec><sec id="s4b">
<title>Strains, media and culture conditions</title>
<p>Wild-type <italic>M. tuberculosis</italic> (H37Rv) was obtained from Dr. Robert North, Trudeau Institute. Mycobacteria were grown at 37°C in Middlebrook 7H9 medium (Difco) containing 0.2% glycerol, 0.5% bovine serum albumin, 0.2% dextrose, 0.085% NaCl, and 0.05% Tween 80. Hygromycin B (50 mg/ml), kanamycin (15 mg/ml) and streptomycin (20 mg/ml) were included when required for selection.</p>
</sec><sec id="s4c">
<title>Construction of <italic>ΔprcBA</italic></title>
<p><italic>PrcBA</italic> genes were deleted from the chromosome via homologous recombination following transduction with temperature-sensitive mycobacteriophage phAE87 <xref ref-type="bibr" rid="ppat.1001040-Bardarov1">[58]</xref>. 768 bp upstream of the start codon of <italic>prcB</italic> and 524 bp downstream of the stop codon of <italic>prcA</italic> were amplified by PCR from H37Rv genomic DNA and cloned into pJSC284 to flank the hygromycin resistance gene. pJSC284 is a derivative of pYUB854 containing a lambda cos site, and a unique <italic>Pac</italic>I site. The resulting plasmid was ligated with the temperature-sensitive phage phAE87 and the resulting phage was used to infect <italic>M. tuberculosis</italic>. Hygromycin-resistant transductants were selected on 7H11 agar plates with 50 µg/ml hygromycin for 3 weeks and analyzed by Southern blot.</p>
</sec><sec id="s4d">
<title>Complementation of <italic>ΔprcBA</italic></title>
<p><italic>PrcBA</italic> were PCR amplified from H37Rv genomic DNA with a forward primer specific to <italic>prcB</italic> (<named-content content-type="gene" xlink:type="simple">5′- CGTCCGCGCATGCGTCCAGGAGGGCGGACAG-3′</named-content>) and a reverse primer specific to <italic>prcA</italic> (<named-content content-type="gene" xlink:type="simple">5′-GACACGCGTCGGACGTTTAAACTCAGCCCG-3′</named-content>). The resulting fragment was cloned into an episomal mycobacterial plasmid containing the mycobacterial promoter P<sub>myc1</sub>tetO <xref ref-type="bibr" rid="ppat.1001040-Ehrt1">[59]</xref> and a kanamycin resistance gene.</p>
</sec><sec id="s4e">
<title>Construction of T1A proteasome mutant</title>
<p><italic>PrcA</italic> was PCR amplified using primers <named-content content-type="gene" xlink:type="simple">5′- CGGGTGCGCATGCTTTCGGCTCCGAAGGAGGTGAG-3′</named-content> and <named-content content-type="gene" xlink:type="simple">5′-ACTCAGCCCGACGATTCGCCGTCAGACTGC-3′</named-content> resulting in introduction of an <italic>Sph</italic>I site at the 5′ end of <italic>prcA</italic> followed by a synthetic ribosome binding site (RBS). <italic>prcB</italic> was PCR amplified using primers <named-content content-type="gene" xlink:type="simple">5′-GGCCACCATTGTCGCGCTGAAATACCCC-3′</named-content> and <named-content content-type="gene" xlink:type="simple">5′- CGCCTGCTCTGCAGTCAATGATGATGATGATGATGCTTCTCACCGCCATCGGAGCCGAAAGTATCC-3′</named-content> from the H37Rv genome resulting in deletion of the 5′ end encoding its pro-peptide, mutation of threonine 1 to alanine and addition of a C terminal hexahistidine tag, followed by a PstI site 3′ of <italic>prcB</italic>-T1AHis<sub>6</sub> (encoded protein referred to as PrcAB-T1A). For expression of the active proteasome, <italic>prcBA</italic> was amplified from the H37Rv genome using primers <named-content content-type="gene" xlink:type="simple">5′- CGTCCGCGCATGCGTCCAGGAGGGCGGACAG-3′</named-content> and <named-content content-type="gene" xlink:type="simple">5′-GGGGGCCCATCGATCTCTTAATTAAGGTAGAC-3′</named-content>. The amplified fragments were cloned into an episomal mycobacterial plasmid containing the mycobacterial promoter P<sub>myc1</sub>tetO <xref ref-type="bibr" rid="ppat.1001040-Ehrt1">[59]</xref> and a kanamycin resistance gene.</p>
</sec><sec id="s4f">
<title>Construction of PanB-GFP expression vector</title>
<p>The <italic>panB-gfp</italic> fusion was generated by PCR and cloned using the Gateway Cloning Technology (Invitrogen) behind a constitutive promoter into an integrative mycobacterial plasmid containing a streptomycin resistance gene.</p>
</sec><sec id="s4g">
<title>Immunoblots</title>
<p>Cell lysates were prepared by bead-beating the cell pellets in PBS containing protease inhibitor cocktail (Complete Mini, Roche). Clarified cell lysates were filter sterilized by passage through a 0.2 µm filter. 15 µg cell lysates were subjected to SDS-PAGE, followed by transfer to a nitrocellulose membrane. Blots were probed with PrcB-specific and DlaT-specific rabbit sera at 1∶15,000 and 1∶10,000 dilutions in 5% skimmed-milk containing Tris-buffered saline with 0.05% Tween 20 (TBST). To assess PanB-GFP accumulation, blots were probed with anti-GFP antibody (Invitrogen). Secondary antibodies, donkey anti-rabbit (horse radish peroxidase coupled) or LI-COR 800 goat anti rabbit were used at 1∶30,000 dilution in 2% skimmed-milk containing TBST and at 1∶15,000 dilution in Odyssey blocking buffer, respectively. Blots were developed using Immobilon Western Chemiluminescent HRP substrate (Millipore) or using the Odyssey Infrared Imaging System (LI-COR Biosciences).</p>
</sec><sec id="s4h">
<title>Proteasome activity assay</title>
<p>Bacteria were grown to OD<sub>580nm</sub> 1.0, washed as described above and cell pellets were lysed in 450 µl PBS containing protease inhibitor cocktail (Complete Mini, Roche) using a bead beater. Clarified cell lysates were filter sterilized by passage through a 0.2 µm filter and then adjusted to a final glycerol concentration of 10%. Proteasome activity was assessed as previously described <xref ref-type="bibr" rid="ppat.1001040-Lin1">[12]</xref>. Briefly, 50 µg of lysate were incubated with 100 µM Succinyl-Leu-Leu-Val-Tyr-aminomethyl coumarin (Suc-LLVY-AMC) in 20 mM HEPES, 0.5 mM EDTA buffer and fluorescence was monitored at excitation of 370 nm and emission of 430 nm at 37°C over 60 min in a 96 well-plate fluorimeter (Molecular Devices).</p>
</sec><sec id="s4i">
<title>Determination of in vivo GFP and PanB-GFP accumulation</title>
<p>Cultures were grown to OD<sub>580nm</sub> 0.4–0.9 (mid log) and 1.0–1.5 ml of cultures were harvested, resuspended in 100 ml PBS and aliquoted into a black 96 well plate. Fluorescence was measured using excitation at 485 nm and emission at 515 nm. Relative fluorescence units were normalized to OD<sub>580nm</sub>.</p>
</sec><sec id="s4j">
<title><italic>In vitro</italic> stress susceptibility assays</title>
<p>Cultures were grown to log phase (OD<sub>580nm</sub> 0.6), washed in growth medium and single cell suspensions prepared in assay medium by centrifugation at 800 rpm for 12 minutes. Single cell suspensions were subsequently diluted to OD<sub>580nm</sub> 0.01. To test susceptibility to RNI, diluted cultures were incubated at pH 5.5 with or without 3mM or 5mM NaNO<sub>2</sub> for 3 days at 37°C. To determine viability, serial dilutions of cultures were plated on 7H11 plates.</p>
</sec><sec id="s4k">
<title>Stationary phase survival and starvation assays</title>
<p>For long-term survival experiments <italic>M. tuberculosis</italic> strains were grown in 7H9 medium to mid log phase. Single cell suspensions were prepared in 7H9 as described above and diluted into fresh medium to OD<sub>580n</sub> 0.01, in 10 ml triplicate cultures. For starvation conditions, single cell suspensions were prepared in PBS with 0.02% Tween 80 and diluted into PBS-Tween to OD<sub>580n</sub> 0.01 in triplicate 10 ml cultures. Cultures were incubated at 37°C under constant shaking (50 rpm). To determine growth and viability, serial dilutions of cultures were plated on 7H11 plates.</p>
</sec><sec id="s4l">
<title>Animal infections</title>
<p>Eight week old, female C57BL/6 mice (Jackson Laboratory) were infected with <italic>M. tuberculosis</italic> strains by aerosol as described <xref ref-type="bibr" rid="ppat.1001040-Gandotra1">[24]</xref>. Bacterial numbers in organs were enumerated by plating organ homogenates for colony forming units (CFU) at indicated times. N6-(1-Iminoethyl)lysine (NIL; L- and D-enantiomers) (custom synthesized by DeCODE Chemicals <xref ref-type="bibr" rid="ppat.1001040-Dumont1">[60]</xref>, and a kind gift from Dr. C. Nathan) were given in acidified (pH 2.7) drinking water (4 mM) beginning on day 21 post infection and freshly prepared every 48 hr until the end of the experiment <xref ref-type="bibr" rid="ppat.1001040-MacMicking1">[26]</xref>.</p>
</sec></sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="ppat.1001040.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.ppat.1001040.s001" xlink:type="simple"><label>Figure S1</label><caption>
<p>Genetic deletion of <italic>prcBA</italic>. (A) Map of the <italic>prcBA</italic> genomic region in wt <italic>M. tuberculosis</italic> (top) and Δ<italic>prcBA</italic> (bottom). Probe location and <italic>Bam</italic>HI (B) restriction sites are indicated. (B) Southern blot of <italic>Bam</italic>HI (B) digested genomic DNA from wt <italic>M. tuberculosis</italic> (H37Rv) and Δ<italic>prcBA</italic> probed with the DNA fragment indicated in (A). (C) PrcB levels analyzed by immunoblot in H37Rv, Δ<italic>prcBA</italic> and the complemented mutant (Δ<italic>prcBA</italic> + PrcBA). Dihydrolipoamide acyltransferase (DlaT) was used as loading control.</p>
<p>(0.80 MB TIF)</p>
</caption></supplementary-material><supplementary-material id="ppat.1001040.s002" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.ppat.1001040.s002" xlink:type="simple"><label>Figure S2</label><caption>
<p>PrcBA complex formation. (A) Immunoprecipitation of PrcBHis6 and PrcB-T1AHis6 co-purified PrcA. Cell lysates from 100 ml cultures (20 mg total protein) of the indicated <italic>M. tuberculosis</italic> strains were immunoprecipitated with anti-histidine beads (Invitrogen). Protein eluted from the beads (E) with 1 M imidazol and protein recovered from boiled beads (B) were separated on a 15% SDS Page. (B) Identification of PrcB and PrcA by peptide mass finger printing and N-terminal sequencing. N-terminal sequencing of proteins from band 2 and 4 identified the expected N-terminal threonine for PrcB in band 2 and an N-terminal alanine residue for PrcB-T1A in band 4.</p>
<p>(0.31 MB PDF)</p>
</caption></supplementary-material></sec></body>
<back>
<ack>
<p>We thank H. Yu and H. Deng of the Rockefeller Proteomics Resource Center for mass spectrometry analysis; D. Schnappinger for plasmids and helpful suggestions; G. Lin and C. Nathan for anti-PrcB antiserum; R. Bryk and C. Nathan for anti-DlaT antiserum; E. Hwang for technical support; C. Nathan and G. Lin for helpful discussions; and D. Schnappinger, K. Rhee and C. Nathan for review. The Department of Microbiology and Immunology acknowledges the support of the William Randolph Hearst Foundation.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="ppat.1001040-Arrigo1"><label>1</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Arrigo</surname><given-names>AP</given-names></name>
<name name-style="western"><surname>Tanaka</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Goldberg</surname><given-names>AL</given-names></name>
<name name-style="western"><surname>Welch</surname><given-names>WJ</given-names></name>
</person-group>             <year>1988</year>             <article-title>Identity of the 19S ‘prosome’ particle with the large multifunctional protease complex of mammalian cells (the proteasome).</article-title>             <source>Nature</source>             <volume>331</volume>             <fpage>192</fpage>             <lpage>194</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Baumeister1"><label>2</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Baumeister</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Dahlmann</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Hegerl</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Kopp</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Kuehn</surname><given-names>L</given-names></name>
<etal/></person-group>             <year>1988</year>             <article-title>Electron microscopy and image analysis of the multicatalytic proteinase.</article-title>             <source>FEBS Lett</source>             <volume>241</volume>             <fpage>239</fpage>             <lpage>245</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Kisselev1"><label>3</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kisselev</surname><given-names>AF</given-names></name>
<name name-style="western"><surname>Songyang</surname><given-names>Z</given-names></name>
<name name-style="western"><surname>Goldberg</surname><given-names>AL</given-names></name>
</person-group>             <year>2000</year>             <article-title>Why does threonine, and not serine, function as the active site nucleophile in proteasomes?</article-title>             <source>J Biol Chem</source>             <volume>275</volume>             <fpage>14831</fpage>             <lpage>14837</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Lupas1"><label>4</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lupas</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Zuhl</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Tamura</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Wolf</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Nagy</surname><given-names>I</given-names></name>
<etal/></person-group>             <year>1997</year>             <article-title>Eubacterial proteasomes.</article-title>             <source>Mol Biol Rep</source>             <volume>24</volume>             <fpage>125</fpage>             <lpage>131</lpage>          </element-citation></ref>
<ref id="ppat.1001040-DeMot1"><label>5</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>De Mot</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Nagy</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Walz</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Baumeister</surname><given-names>W</given-names></name>
</person-group>             <year>1999</year>             <article-title>Proteasomes and other self-compartmentalizing proteases in prokaryotes.</article-title>             <source>Trends Microbiol</source>             <volume>7</volume>             <fpage>88</fpage>             <lpage>92</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Gottesman1"><label>6</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Gottesman</surname><given-names>S</given-names></name>
</person-group>             <year>2003</year>             <article-title>Proteolysis in bacterial regulatory circuits.</article-title>             <source>Annu Rev Cell Dev Biol</source>             <volume>19</volume>             <fpage>565</fpage>             <lpage>587</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Cole1"><label>7</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Cole</surname><given-names>ST</given-names></name>
<name name-style="western"><surname>Brosch</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Parkhill</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Garnier</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Churcher</surname><given-names>C</given-names></name>
<etal/></person-group>             <year>1998</year>             <article-title>Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.</article-title>             <source>Nature</source>             <volume>393</volume>             <fpage>537</fpage>             <lpage>544</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Darwin1"><label>8</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Darwin</surname><given-names>KH</given-names></name>
<name name-style="western"><surname>Ehrt</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Gutierrez-Ramos</surname><given-names>JC</given-names></name>
<name name-style="western"><surname>Weich</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Nathan</surname><given-names>CF</given-names></name>
</person-group>             <year>2003</year>             <article-title>The proteasome of <italic>Mycobacterium tuberculosis</italic> is required for resistance to nitric oxide.</article-title>             <source>Science</source>             <volume>302</volume>             <fpage>1963</fpage>             <lpage>1966</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Darwin2"><label>9</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Darwin</surname><given-names>KH</given-names></name>
<name name-style="western"><surname>Lin</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name>
<name name-style="western"><surname>Li</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Nathan</surname><given-names>CF</given-names></name>
</person-group>             <year>2005</year>             <article-title>Characterization of a <italic>Mycobacterium tuberculosis</italic> proteasomal ATPase homologue.</article-title>             <source>Mol Microbiol</source>             <volume>55</volume>             <fpage>561</fpage>             <lpage>571</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Neuwald1"><label>10</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Neuwald</surname><given-names>AF</given-names></name>
<name name-style="western"><surname>Aravind</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Spouge</surname><given-names>JL</given-names></name>
<name name-style="western"><surname>Koonin</surname><given-names>EV</given-names></name>
</person-group>             <year>1999</year>             <article-title>AAA+: A class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes.</article-title>             <source>Genome Res</source>             <volume>9</volume>             <fpage>27</fpage>             <lpage>43</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Hu1"><label>11</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hu</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Lin</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Dick</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Xu</surname><given-names>RM</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Structure of the <italic>Mycobacterium tuberculosis</italic> proteasome and mechanism of inhibition by a peptidyl boronate.</article-title>             <source>Mol Microbiol</source>             <volume>59</volume>             <fpage>1417</fpage>             <lpage>1428</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Lin1"><label>12</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lin</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Hu</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Tsu</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Kunes</surname><given-names>YZ</given-names></name>
<name name-style="western"><surname>Li</surname><given-names>H</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title><italic>Mycobacterium tuberculosis prcBA</italic> genes encode a gated proteasome with broad oligopeptide specificity.</article-title>             <source>Mol Microbiol</source>             <volume>59</volume>             <fpage>1405</fpage>             <lpage>1416</lpage>          </element-citation></ref>
<ref id="ppat.1001040-CerdaMaira1"><label>13</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Cerda-Maira</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Darwin</surname><given-names>KH</given-names></name>
</person-group>             <year>2009</year>             <article-title>The <italic>Mycobacterium tuberculosis</italic> proteasome: more than just a barrel-shaped protease.</article-title>             <source>Microbes Infect</source>             <volume>11</volume>             <fpage>1150</fpage>             <lpage>1155</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Wang1"><label>14</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Wang</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Li</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Lin</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Tang</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Li</surname><given-names>D</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Structural insights on the <italic>Mycobacterium tuberculosis</italic> proteasomal ATPase Mpa.</article-title>             <source>Structure</source>             <volume>17</volume>             <fpage>1377</fpage>             <lpage>1385</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Kerscher1"><label>15</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kerscher</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Felberbaum</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Hochstrasser</surname><given-names>M</given-names></name>
</person-group>             <year>2006</year>             <article-title>Modification of proteins by ubiquitin and ubiquitin-like proteins.</article-title>             <source>Annu Rev Cell Dev Biol</source>             <volume>22</volume>             <fpage>159</fpage>             <lpage>180</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Pearce1"><label>16</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Pearce</surname><given-names>MJ</given-names></name>
<name name-style="western"><surname>Mintseris</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Ferreyra</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Gygi</surname><given-names>SP</given-names></name>
<name name-style="western"><surname>Darwin</surname><given-names>KH</given-names></name>
</person-group>             <year>2008</year>             <article-title>Ubiquitin-like protein involved in the proteasome pathway of <italic>Mycobacterium tuberculosis</italic>.</article-title>             <source>Science</source>             <volume>322</volume>             <fpage>1104</fpage>             <lpage>1107</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Burns1"><label>17</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Burns</surname><given-names>KE</given-names></name>
<name name-style="western"><surname>Liu</surname><given-names>WT</given-names></name>
<name name-style="western"><surname>Boshoff</surname><given-names>HI</given-names></name>
<name name-style="western"><surname>Dorrestein</surname><given-names>PC</given-names></name>
<name name-style="western"><surname>Barry</surname><given-names>CE</given-names><suffix>3rd</suffix></name>
</person-group>             <year>2009</year>             <article-title>Proteasomal protein degradation in Mycobacteria is dependent upon a prokaryotic ubiquitin-like protein.</article-title>             <source>J Biol Chem</source>             <volume>284</volume>             <fpage>3069</fpage>             <lpage>3075</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Striebel1"><label>18</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Striebel</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Imkamp</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Sutter</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Steiner</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Mamedov</surname><given-names>A</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Bacterial ubiquitin-like modifier Pup is deamidated and conjugated to substrates by distinct but homologous enzymes.</article-title>             <source>Nat Struct Mol Biol</source>             <volume>16</volume>             <fpage>647</fpage>             <lpage>651</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Imkamp1"><label>19</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Imkamp</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Rosenberger</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Striebel</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Keller</surname><given-names>PM</given-names></name>
<name name-style="western"><surname>Amstutz</surname><given-names>B</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Deletion of dop in <italic>Mycobacterium smegmatis</italic> abolishes pupylation of protein substrates in vivo.</article-title>             <source>Mol Microbiol</source>             <volume>75</volume>             <fpage>744</fpage>             <lpage>754</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Striebel2"><label>20</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Striebel</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Hunkeler</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Summer</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Weber-Ban</surname><given-names>E</given-names></name>
</person-group>             <year>2010</year>             <article-title>The mycobacterial Mpa-proteasome unfolds and degrades pupylated substrates by engaging Pup's N-terminus.</article-title>             <source>EMBO J</source>          </element-citation></ref>
<ref id="ppat.1001040-Festa1"><label>21</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Festa</surname><given-names>RA</given-names></name>
<name name-style="western"><surname>McAllister</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Pearce</surname><given-names>MJ</given-names></name>
<name name-style="western"><surname>Mintseris</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Burns</surname><given-names>KE</given-names></name>
<etal/></person-group>             <year>2010</year>             <article-title>Prokayrotic ubiquitin-like protein (Pup) proteome of <italic>Mycobacterium tuberculosis</italic>.</article-title>             <source>PLoS One</source>             <volume>5</volume>             <fpage>e8589</fpage>          </element-citation></ref>
<ref id="ppat.1001040-Watrous1"><label>22</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Watrous</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Burns</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Liu</surname><given-names>WT</given-names></name>
<name name-style="western"><surname>Patel</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Hook</surname><given-names>V</given-names></name>
<etal/></person-group>             <year>2010</year>             <article-title>Expansion of the mycobacterial “PUPylome”.</article-title>             <source>Mol Biosyst</source>             <volume>6</volume>             <fpage>376</fpage>             <lpage>385</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Rhee1"><label>23</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Rhee</surname><given-names>KY</given-names></name>
<name name-style="western"><surname>Erdjument-Bromage</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Tempst</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Nathan</surname><given-names>CF</given-names></name>
</person-group>             <year>2005</year>             <article-title>S-nitroso proteome of <italic>Mycobacterium tuberculosis</italic>: Enzymes of intermediary metabolism and antioxidant defense.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>102</volume>             <fpage>467</fpage>             <lpage>472</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Gandotra1"><label>24</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Gandotra</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Schnappinger</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Monteleone</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Hillen</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Ehrt</surname><given-names>S</given-names></name>
</person-group>             <year>2007</year>             <article-title>In vivo gene silencing identifies the <italic>Mycobacterium tuberculosis</italic> proteasome as essential for the bacteria to persist in mice.</article-title>             <source>Nature Medicine</source>             <volume>13</volume>             <fpage>1515</fpage>             <lpage>1520</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Sassetti1"><label>25</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Sassetti</surname><given-names>CM</given-names></name>
<name name-style="western"><surname>Boyd</surname><given-names>DH</given-names></name>
<name name-style="western"><surname>Rubin</surname><given-names>EJ</given-names></name>
</person-group>             <year>2003</year>             <article-title>Genes required for mycobacterial growth defined by high density mutagenesis.</article-title>             <source>Mol Microbiol</source>             <volume>48</volume>             <fpage>77</fpage>             <lpage>84</lpage>          </element-citation></ref>
<ref id="ppat.1001040-MacMicking1"><label>26</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>MacMicking</surname><given-names>JD</given-names></name>
<name name-style="western"><surname>North</surname><given-names>RJ</given-names></name>
<name name-style="western"><surname>LaCourse</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Mudgett</surname><given-names>JS</given-names></name>
<name name-style="western"><surname>Shah</surname><given-names>SK</given-names></name>
<etal/></person-group>             <year>1997</year>             <article-title>Identification of nitric oxide synthase as a protective locus against tuberculosis.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>94</volume>             <fpage>5243</fpage>             <lpage>5248</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Moore1"><label>27</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Moore</surname><given-names>WM</given-names></name>
<name name-style="western"><surname>Webber</surname><given-names>RK</given-names></name>
<name name-style="western"><surname>Jerome</surname><given-names>GM</given-names></name>
<name name-style="western"><surname>Tjoeng</surname><given-names>FS</given-names></name>
<name name-style="western"><surname>Misko</surname><given-names>TP</given-names></name>
<etal/></person-group>             <year>1994</year>             <article-title>L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase.</article-title>             <source>J Med Chem</source>             <volume>37</volume>             <fpage>3886</fpage>             <lpage>3888</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Stenger1"><label>28</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Stenger</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Thuring</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Rollinghoff</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Manning</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Bogdan</surname><given-names>C</given-names></name>
</person-group>             <year>1995</year>             <article-title>L-N6-(1-iminoethyl)-lysine potently inhibits inducible nitric oxide synthase and is superior to NG-monomethyl-arginine in vitro and in vivo.</article-title>             <source>Eur J Pharmacol</source>             <volume>294</volume>             <fpage>703</fpage>             <lpage>712</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Seemuller1"><label>29</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Seemuller</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Lupas</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Baumeister</surname><given-names>W</given-names></name>
</person-group>             <year>1996</year>             <article-title>Autocatalytic processing of the 20S proteasome.</article-title>             <source>Nature</source>             <volume>382</volume>             <fpage>468</fpage>             <lpage>471</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Seemuller2"><label>30</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Seemuller</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Lupas</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Stock</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Lowe</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Huber</surname><given-names>R</given-names></name>
<etal/></person-group>             <year>1995</year>             <article-title>Proteasome from Thermoplasma acidophilum: a threonine protease.</article-title>             <source>Science</source>             <volume>268</volume>             <fpage>579</fpage>             <lpage>582</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Zuhl1"><label>31</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Zuhl</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Seemuller</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Golbik</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Baumeister</surname><given-names>W</given-names></name>
</person-group>             <year>1997</year>             <article-title>Dissecting the assembly pathway of the 20S proteasome.</article-title>             <source>FEBS Lett</source>             <volume>418</volume>             <fpage>189</fpage>             <lpage>194</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Zwickl1"><label>32</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Zwickl</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Kleinz</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Baumeister</surname><given-names>W</given-names></name>
</person-group>             <year>1994</year>             <article-title>Critical elements in proteasome assembly.</article-title>             <source>Nat Struct Biol</source>             <volume>1</volume>             <fpage>765</fpage>             <lpage>770</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Pearce2"><label>33</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Pearce</surname><given-names>MJ</given-names></name>
<name name-style="western"><surname>Arora</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Festa</surname><given-names>RA</given-names></name>
<name name-style="western"><surname>Butler-Wu</surname><given-names>SM</given-names></name>
<name name-style="western"><surname>Gokhale</surname><given-names>RS</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Identification of substrates of the <italic>Mycobacterium tuberculosis</italic> proteasome.</article-title>             <source>EMBO J</source>             <volume>25</volume>             <fpage>5423</fpage>             <lpage>5432</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Damerau1"><label>34</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Damerau</surname><given-names>K</given-names></name>
<name name-style="western"><surname>St John</surname><given-names>AC</given-names></name>
</person-group>             <year>1993</year>             <article-title>Role of Clp protease subunits in degradation of carbon starvation proteins in <italic>Escherichia coli</italic>.</article-title>             <source>J Bacteriol</source>             <volume>175</volume>             <fpage>53</fpage>             <lpage>63</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Kuroda1"><label>35</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kuroda</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Nomura</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Ohtomo</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Kato</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Ikeda</surname><given-names>T</given-names></name>
<etal/></person-group>             <year>2001</year>             <article-title>Role of inorganic polyphosphate in promoting ribosomal protein degradation by the Lon protease in E. coli.</article-title>             <source>Science</source>             <volume>293</volume>             <fpage>705</fpage>             <lpage>708</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Dahlmann1"><label>36</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Dahlmann</surname><given-names>B</given-names></name>
</person-group>             <year>2007</year>             <article-title>Role of proteasomes in disease.</article-title>             <source>BMC Biochem</source>             <volume>8</volume>             <supplement>Suppl 1</supplement>             <fpage>S3</fpage>          </element-citation></ref>
<ref id="ppat.1001040-Jung1"><label>37</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Jung</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Catalgol</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Grune</surname><given-names>T</given-names></name>
</person-group>             <year>2009</year>             <article-title>The proteasomal system.</article-title>             <source>Mol Aspects Med</source>             <volume>30</volume>             <fpage>191</fpage>             <lpage>296</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Ruepp1"><label>38</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ruepp</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Eckerskorn</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Bogyo</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Baumeister</surname><given-names>W</given-names></name>
</person-group>             <year>1998</year>             <article-title>Proteasome function is dispensable under normal but not under heat shock conditions in <italic>Thermoplasma acidophilum</italic>.</article-title>             <source>FEBS Lett</source>             <volume>425</volume>             <fpage>87</fpage>             <lpage>90</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Hong1"><label>39</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hong</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Lammertyn</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Geukens</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Van Mellaert</surname><given-names>L</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>Inactivation of the 20S proteasome in <italic>Streptomyces lividans</italic> and its influence on the production of heterologous proteins.</article-title>             <source>Microbiology</source>             <volume>151</volume>             <fpage>3137</fpage>             <lpage>3145</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Knipfer1"><label>40</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Knipfer</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Shrader</surname><given-names>TE</given-names></name>
</person-group>             <year>1997</year>             <article-title>Inactivation of the 20S proteasome in <italic>Mycobacterium smegmatis</italic>.</article-title>             <source>Mol Microbiol</source>             <volume>25</volume>             <fpage>375</fpage>             <lpage>383</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Nagy1"><label>41</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Nagy</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Banerjee</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Tamura</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Schoofs</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Gils</surname><given-names>A</given-names></name>
<etal/></person-group>             <year>2003</year>             <article-title>Characterization of a novel intracellular endopeptidase of the alpha/beta hydrolase family from <italic>Streptomyces coelicolor</italic> A3(2).</article-title>             <source>J Bacteriol</source>             <volume>185</volume>             <fpage>496</fpage>             <lpage>503</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Darwin3"><label>42</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Darwin</surname><given-names>KH</given-names></name>
</person-group>             <year>2009</year>             <article-title>Prokaryotic ubiquitin-like protein (Pup), proteasomes and pathogenesis.</article-title>             <source>Nat Rev Microbiol</source>             <volume>7</volume>             <fpage>485</fpage>             <lpage>491</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Chen1"><label>43</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Chen</surname><given-names>ZJ</given-names></name>
<name name-style="western"><surname>Sun</surname><given-names>LJ</given-names></name>
</person-group>             <year>2009</year>             <article-title>Nonproteolytic functions of ubiquitin in cell signaling.</article-title>             <source>Mol Cell</source>             <volume>33</volume>             <fpage>275</fpage>             <lpage>286</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Ferdous1"><label>44</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ferdous</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Kodadek</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Johnston</surname><given-names>SA</given-names></name>
</person-group>             <year>2002</year>             <article-title>A nonproteolytic function of the 19S regulatory subunit of the 26S proteasome is required for efficient activated transcription by human RNA polymerase II.</article-title>             <source>Biochemistry</source>             <volume>41</volume>             <fpage>12798</fpage>             <lpage>12805</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Nishiyama1"><label>45</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Nishiyama</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Tachibana</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Igarashi</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Yasuda</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Tanahashi</surname><given-names>N</given-names></name>
<etal/></person-group>             <year>2000</year>             <article-title>A nonproteolytic function of the proteasome is required for the dissociation of Cdc2 and cyclin B at the end of M phase.</article-title>             <source>Genes Dev</source>             <volume>14</volume>             <fpage>2344</fpage>             <lpage>2357</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Betts1"><label>46</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Betts</surname><given-names>JC</given-names></name>
<name name-style="western"><surname>Lukey</surname><given-names>PT</given-names></name>
<name name-style="western"><surname>Robb</surname><given-names>LC</given-names></name>
<name name-style="western"><surname>McAdam</surname><given-names>RA</given-names></name>
<name name-style="western"><surname>Duncan</surname><given-names>K</given-names></name>
</person-group>             <year>2002</year>             <article-title>Evaluation of a nutrient starvation model of <italic>Mycobacterium tuberculosis</italic> persistence by gene and protein expression profiling.</article-title>             <source>Mol Microbiol</source>             <volume>43</volume>             <fpage>717</fpage>             <lpage>731</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Nyka1"><label>47</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Nyka</surname><given-names>W</given-names></name>
</person-group>             <year>1974</year>             <article-title>Studies on the effect of starvation on mycobacteria.</article-title>             <source>Infect Immun</source>             <volume>9</volume>             <fpage>843</fpage>             <lpage>850</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Wayne1"><label>48</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Wayne</surname><given-names>LG</given-names></name>
<name name-style="western"><surname>Hayes</surname><given-names>LG</given-names></name>
</person-group>             <year>1996</year>             <article-title>An in vitro model for sequential study of shiftdown of <italic>Mycobacterium tuberculosis</italic> through two stages of nonreplicating persistence.</article-title>             <source>Infect Immun</source>             <volume>64</volume>             <fpage>2062</fpage>             <lpage>2069</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Loebel1"><label>49</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Loebel</surname><given-names>RO</given-names></name>
<name name-style="western"><surname>Shorr</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Richardson</surname><given-names>HB</given-names></name>
</person-group>             <year>1933</year>             <article-title>The Influence of Adverse Conditions upon the Respiratory Metabolism and Growth of Human Tubercle Bacilli.</article-title>             <source>J Bacteriol</source>             <volume>26</volume>             <fpage>167</fpage>             <lpage>200</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Loebel2"><label>50</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Loebel</surname><given-names>RO</given-names></name>
<name name-style="western"><surname>Shorr</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Richardson</surname><given-names>HB</given-names></name>
</person-group>             <year>1933</year>             <article-title>The Influence of Foodstuffs upon the Respiratory Metabolism and Growth of Human Tubercle Bacilli.</article-title>             <source>J Bacteriol</source>             <volume>26</volume>             <fpage>139</fpage>             <lpage>166</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Fenhalls1"><label>51</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Fenhalls</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Stevens</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Moses</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Bezuidenhout</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Betts</surname><given-names>JC</given-names></name>
<etal/></person-group>             <year>2002</year>             <article-title>In situ detection of <italic>Mycobacterium tuberculosis</italic> transcripts in human lung granulomas reveals differential gene expression in necrotic lesions.</article-title>             <source>Infect Immun</source>             <volume>70</volume>             <fpage>6330</fpage>             <lpage>6338</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Dahl1"><label>52</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Dahl</surname><given-names>JL</given-names></name>
<name name-style="western"><surname>Kraus</surname><given-names>CN</given-names></name>
<name name-style="western"><surname>Boshoff</surname><given-names>HI</given-names></name>
<name name-style="western"><surname>Doan</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Foley</surname><given-names>K</given-names></name>
<etal/></person-group>             <year>2003</year>             <article-title>The role of Rel Mtb-mediated adaptation to stationary phase in long-term persistence of <italic>Mycobacterium tuberculosis</italic> in mice.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>100</volume>             <fpage>10026</fpage>             <lpage>10031</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Primm1"><label>53</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Primm</surname><given-names>TP</given-names></name>
<name name-style="western"><surname>Andersen</surname><given-names>SJ</given-names></name>
<name name-style="western"><surname>Mizrahi</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Avarbock</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Rubin</surname><given-names>H</given-names></name>
<etal/></person-group>             <year>2000</year>             <article-title>The stringent response of <italic>Mycobacterium tuberculosis</italic> is required for long-term survival.</article-title>             <source>J Bacteriol</source>             <volume>182</volume>             <fpage>4889</fpage>             <lpage>4898</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Stallings1"><label>54</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Stallings</surname><given-names>CL</given-names></name>
<name name-style="western"><surname>Stephanou</surname><given-names>NC</given-names></name>
<name name-style="western"><surname>Chu</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Hochschild</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Nickels</surname><given-names>BE</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>CarD is an essential regulator of rRNA transcription required for <italic>Mycobacterium tuberculosis</italic> persistence.</article-title>             <source>Cell</source>             <volume>138</volume>             <fpage>146</fpage>             <lpage>159</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Kuroda2"><label>55</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kuroda</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Tanaka</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Ikeda</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Kato</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Takiguchi</surname><given-names>N</given-names></name>
<etal/></person-group>             <year>1999</year>             <article-title>Inorganic polyphosphate kinase is required to stimulate protein degradation and for adaptation to amino acid starvation in <italic>Escherichia coli</italic>.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>96</volume>             <fpage>14264</fpage>             <lpage>14269</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Nystrom1"><label>56</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Nystrom</surname><given-names>T</given-names></name>
</person-group>             <year>2002</year>             <article-title>Translational fidelity, protein oxidation, and senescence: lessons from bacteria.</article-title>             <source>Ageing Res Rev</source>             <volume>1</volume>             <fpage>693</fpage>             <lpage>703</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Vabulas1"><label>57</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Vabulas</surname><given-names>RM</given-names></name>
<name name-style="western"><surname>Hartl</surname><given-names>FU</given-names></name>
</person-group>             <year>2005</year>             <article-title>Protein synthesis upon acute nutrient restriction relies on proteasome function.</article-title>             <source>Science</source>             <volume>310</volume>             <fpage>1960</fpage>             <lpage>1963</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Bardarov1"><label>58</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Bardarov</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Kriakov</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Carriere</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Yu</surname><given-names>SW</given-names></name>
<name name-style="western"><surname>Vaamonde</surname><given-names>C</given-names></name>
<etal/></person-group>             <year>1997</year>             <article-title>Conditionally replicating mycobacteriophages: A system for transposon delivery to <italic>Mycobacterium tuberculosis</italic>.</article-title>             <source>Proceedings Of The National Academy Of Sciences Of The United States Of America</source>             <volume>94</volume>             <fpage>10961</fpage>             <lpage>10966</lpage>          </element-citation></ref>
<ref id="ppat.1001040-Ehrt1"><label>59</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ehrt</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Guo</surname><given-names>XV</given-names></name>
<name name-style="western"><surname>Hickey</surname><given-names>CM</given-names></name>
<name name-style="western"><surname>Ryou</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Monteleone</surname><given-names>M</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor.</article-title>             <source>Nucleic Acids Res</source>             <volume>33</volume>             <fpage>e21</fpage>          </element-citation></ref>
<ref id="ppat.1001040-Dumont1"><label>60</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Dumont</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Wille</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Calingasan</surname><given-names>NY</given-names></name>
<name name-style="western"><surname>Nathan</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Flint Beal</surname><given-names>M</given-names></name>
<etal/></person-group>             <year>2010</year>             <article-title>N-iminoethyl-L-lysine improves memory and reduces amyloid pathology in a transgenic mouse model of amyloid deposition.</article-title>             <source>Neurochem Int</source>             <volume>56</volume>             <fpage>345</fpage>             <lpage>351</lpage>          </element-citation></ref>
</ref-list>

</back>
</article>